Tag: Basilea
Phase 3 Study of Antifungal Fosmanogepix for Candidemia & Invasive Candidiasis
Basilea Pharmaceutica Ltd, a biopharmaceutical company based in Allschwil, Switzerland, has recently announced the launch of the Fosmanogepix Against Standard-of-care Treatment in Invasive Candidiasis...